CASP4 and chronic obstructive pulmonary disease: In conclusion, our study highlights a novel molecular mechanism by which combustion-generated nanoparticles induce the release of the pro-inflammatory IL-18 and IL-33 in a non-canonical caspase-4-dependent inflammasome pathway from PBMCs of unstable/exacerbated COPD patients.